Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Phase IV Clinical Development of Sinuforte (Nasodren) Nasal Spray More
LidoPAIN TV: An Adhesive-Backed Crescent Shaped Patch Delivering Lidocaine Behind the Ear to Relieve the Symptoms of Tinnitus and Vertigo More
Prevention of Platinum-Based Cancer Chemotherapy Hearing Loss: Phase III Clinical Development of Sodium Thiosulphate More
New Indication for Griseofulvin as a Local Treatment for Fungal External Otitis: Shraga Undergoing Clinical Development More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2008 - 85 pages - $1,995
Jan 2011 - 15 pages - $99
Nov 2010 - 15 pages - $99
Sep 2010 - 13 pages - $99
Jul 2010 - 13 pages - $99
Aug 2011 - 65 pages - $2,000
Dec 2010 - 56 pages - $1,000
Nov 2011 - 7 pages - $3,835
Aug 2010 - 25 pages - $99
Sep 2010 - 13 pages - $99
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Aphthous ulcers
- Dental disorder (other)
- Gingivitis
- Gum disease
- Herpes simplex virus type 1 (oral)
- Mouth disorder (other)
- Mucositis oral
- Mucositis, Radiation-induced
- Periodontal disease
- Tooth decay
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us